先天性遺伝子/染色体変化検査:医療機器パイプライン分析2020

【英語タイトル】Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020

GlobalDataが出版した調査資料(GD21MC017)・商品コード:GD21MC017
・発行会社(調査会社):GlobalData
・発行日:2020年11月30日
・ページ数:314
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,776,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Inborn Gene or Chromosome Alterations Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inborn Gene or Chromosome Alterations Tests are the genetic tests used to detect monogenetic disorders (like Cystic Fibrosis, Haemochromatosis, Prothrombin Mutation etc), polygenetic disorders (like Asthma , Atherosclerosis, Diabetes, Hypertension, Osteoporosis, etc), chromosomal disorders (like Down’s Syndrome, Edwards Syndrome etc), polymorphisms (like HLA-Typing etc).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Inborn Gene or Chromosome Alterations Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

❖ レポートの目次 ❖

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Inborn Gene or Chromosome Alterations Overview
3 Products under Development
3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development
3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory
3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path
3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date
3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials
4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies
4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development
4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development
5 Inborn Gene or Chromosome Alterations Companies and Product Overview
6 Inborn Gene or Chromosome Alterations- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Cystic Fibrosis Urine Test - Product Status
Table 10: Cystic Fibrosis Urine Test - Product Description
Table 11: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Molecular Diagnostic Test - Bipolar Disorder - Product Status
Table 13: Molecular Diagnostic Test - Bipolar Disorder - Product Description
Table 14: Molecular Diagnostic Test - Depression - Product Status
Table 15: Molecular Diagnostic Test - Depression - Product Description
Table 16: Molecular Diagnostic Test - Parkinson's Disease - Product Status
Table 17: Molecular Diagnostic Test - Parkinson's Disease - Product Description
Table 18: Molecular Diagnostic Test - Schizophrenia - Product Status
Table 19: Molecular Diagnostic Test - Schizophrenia - Product Description
Table 20: AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Diagnostic Test - Hereditary Deafness - Product Status
Table 22: Diagnostic Test - Hereditary Deafness - Product Description
Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description
Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: SmartPanel - Product Status
Table 28: SmartPanel - Product Description
Table 29: Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: RAD4CHD Test - Product Status
Table 31: RAD4CHD Test - Product Description
Table 32: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Diagnostic Test - IFN-Beta Resistance - Product Status
Table 34: Diagnostic Test - IFN-Beta Resistance - Product Description
Table 35: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Prenatal Screening Kit - Product Status
Table 37: Prenatal Screening Kit - Product Description
Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 39: PDx Pre-Symptomatic Test - Product Status
Table 40: PDx Pre-Symptomatic Test - Product Description
Table 41: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Signature CF Expand - Product Status
Table 43: Signature CF Expand - Product Description
Table 44: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 45: SUMO Gene Test - Type 1 Diabetes - Product Status
Table 46: SUMO Gene Test - Type 1 Diabetes - Product Description
Table 47: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status
Table 49: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description
Table 50: DNA Guided Diagnostic Test - Diabetes - Product Status
Table 51: DNA Guided Diagnostic Test - Diabetes - Product Description
Table 52: DNA Guided Diagnostic Test - Obesity - Product Status
Table 53: DNA Guided Diagnostic Test - Obesity - Product Description
Table 54: INFINITI Neural Response Panel - Product Status

List of Figures
Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

★調査レポート[先天性遺伝子/染色体変化検査:医療機器パイプライン分析2020] (コード:GD21MC017)販売に関する免責事項を必ずご確認ください。
★調査レポート[先天性遺伝子/染色体変化検査:医療機器パイプライン分析2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆